Rock Springs Capital Management LP
Position in NBIX — Neurocrine Biosciences Inc
CIK 1595725
Baltimore, MD
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,820,283
+$2,020,618 QoQ
Shares Held
150,450
+19.9% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rock Springs Capital Management LP holds $43,551,047 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (45.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
150,450 | $19,820,283 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
499,764 | $6,946,719 | |
| 3 | ALKS |
Alkermes plc.
|
183,986 | $6,505,744 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
200,000 | $6,096,000 | |
| 5 | TLPH |
Talphera, Inc.
|
3,589,186 | $2,691,889 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
45,500 | $1,370,460 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
12,600 | $119,952 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,820,283 | 150,450 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,799,665 | 125,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,599,105 | 89,750 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,161,272 | 88,800 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,857,400 | 279,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $98,348,250 | 720,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $108,191,580 | 939,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $129,409,800 | 940,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $145,491,808 | 1,054,900 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $157,584,960 | 1,196,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $139,050,000 | 1,236,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $120,656,850 | 1,279,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $122,486,322 | 1,210,100 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $134,071,400 | 1,122,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $119,220,725 | 1,122,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $109,421,300 | 1,122,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $103,593,750 | 1,105,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $94,112,850 | 1,105,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $100,849,365 | 1,051,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $98,779,800 | 1,015,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $98,708,750 | 1,015,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $150,963,750 | 1,575,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $140,922,480 | 1,465,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $166,713,000 | 1,366,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $116,799,225 | 1,349,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||